AXSM — Axsome Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1579428 ·
Last close
$182.07
Market Cap
$9.54B
52W High
$260.19
52W Low
$117.30
ADV30
652,861
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 218,375,000 | 204,811,000 | -51,142,000 | -51,314,000 | 761,447,000 | 319,850,000 | 678,143,000 |
| Mar 2026 | 191,203,000 | 176,478,000 | -62,767,000 | -64,542,000 | 713,607,000 | 305,106,000 | 659,020,000 |
| Dec 2025 | 195,999,000 | 183,670,000 | -36,025,000 | -28,559,000 | 689,805,000 | 322,933,000 | 601,510,000 |
| Sep 2025 | 170,992,000 | 159,080,000 | -32,924,000 | -47,229,000 | 669,250,000 | 325,272,000 | 595,523,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-70,730,000
Investing CF
$-263,000
Financing CF
$75,189,000
CapEx
$-263,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.73
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,370,503,000
Inventory
$31,515,000
Receivables
$251,062,000
ST Investments
—
EBIT TTM
$-183,522,000
Pretax Income TTM
$-188,833,000
Interest Exp TTM
$5,311,000
Analysts
21
Yahoo Snapshot (yfinance, live)
Total Revenue
$776,569,024
EBITDA
$-172,919,008
Free Cash Flow
$-4,581,750
Enterprise Value
$11,467,908,096
Total Cash
$319,849,984
Total Debt
$224,692,992
Shares Out
52,380,818
Trailing EPS
$-3.75
Book Value
$1.59
ROE
-245.1%
ROA
-16.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 638,496,000 | -169,235,000 | -183,174,000 | 689,805,000 | 601,510,000 | 88,295,000 | -93,405,000 |
| Dec 2024 | 385,693,000 | -252,438,000 | -287,216,000 | 568,498,000 | 511,483,000 | 57,015,000 | -128,410,000 |
| Dec 2023 | 270,600,000 | -182,907,000 | -239,238,000 | 588,236,000 | 397,259,000 | 190,977,000 | -145,080,000 |
| Dec 2022 | 50,037,000 | -176,501,000 | -187,134,000 | 331,476,000 | 221,920,000 | 109,556,000 | -116,511,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$5.03
Max Pain — expiry 2027-01-15
max pain strike: $170.00 · spot: $182.07 · call oi: 7,813 · put oi: 8,142
Expected Move to 2027-01-15:
±$42.60
(23.40%) —
implied range
$139.47 –
$224.67
· ATM straddle on $180.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $9.15B | $64.79 | — |
| CYTK | CYTOKINETICS INC | $9.12B | $65.62 | — |
| PTGX | Protagonist Therapeutics, Inc | $9.01B | $139.19 | — |
| RDY | DR REDDYS LABORATORIES LTD | $10.20B | $12.25 | — |
| ELAN | Elanco Animal Health Inc | $10.87B | $21.77 | — |
News headlines (Yahoo Finance, 1h cache)
Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
2026-10-01 19:17 · Yahoo
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
2026-09-21 11:00 · Yahoo
Axsome Sees AUVELITY Prescriptions Accelerate as Alzheimer’s Launch Gains Traction
2026-09-19 18:02 · Yahoo
Axsome Therapeutics (AXSM) Stock Looks Undervalued As Its 5 Year 7x Run Continues
2026-09-19 13:11 · Yahoo
Is Axsome Therapeutics’ (AXSM) New CNS Data Enough To Reinforce Its Neuropsychiatric Portfolio Story?
2026-09-19 11:14 · Yahoo
Axsome Therapeutics Highlights Auvelity Growth, Pipeline Progress at H.C. Wainwright Conference
2026-09-19 08:02 · Yahoo
Axsome Therapeutics (AXSM) Reported New Clinical Data In Depression And Alzheimer’s Agitation
2026-09-19 04:18 · Yahoo
Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy?
2026-09-18 22:22 · Yahoo
Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
2026-09-18 19:25 · Yahoo
Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
2026-09-18 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.